Copy Link Print Information

NAD+ lithium

(Synonyms: β-DPN lithium; β-NAD lithium; β-Nicotinamide Adenine Dinucleotide lithium)
50 Cited Publications
Revisión del cliente

Based on 50 publication(s) in Google Scholar

NAD+ lithium (β-DPN lithium) is a lithium salt of nicotinamide adenine dinucleotide. NAD+ is a coenzyme in the REDOX reaction. NAD+ can directly or indirectly affect several key cellular functions, including metabolic pathways, DNA repair, chromatin remodeling, cell aging, and immune cell function.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.49%
  • No. CAS: 64417-72-7
  • Fòrmula: C21H26LiN7O14P2
  • Peso molecular:669.36
  • Almacenamiento:
    Powder   -20°C, 3 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • NAD+ lithium Chemical Structure
    NAD+ lithium Chemical Structure
  • Experimental Validation Results for NAD+ lithium
  • Experimental Validation Results for NAD+ lithium
  • Experimental Validation Results for NAD+ lithium
  • Experimental Validation Results for NAD+ lithium
  • Experimental Validation Results for NAD+ lithium
  • Experimental Validation Results for NAD+ lithium
  • Experimental Validation Results for NAD+ lithium
  • Experimental Validation Results for NAD+ lithium
No. CAS: 64417-72-7
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of NAD+ lithium:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) NAD+ lithium

More
Customer Validation & Images
Cell Proliferation/Viability AssayIPRT-PCRWBIF
  • Cell Proliferation/Viability Assay
  • RT-PCR
  • WB
  • WB
  • WB
  • IP
  • IF
  • IF
Keywords
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • NAD+ lithium Chemical Structure
    NAD+ lithium Chemical Structure
    1/16
  • 1/16

    NAD+ lithium purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Feb:69:103030. [Abstract]

    Customer Validation
     LDH release assay showed the glioma cell death caused by SRT2183 (40 μmol/L) at 24 h was attenuated when the cells were pretreated 1 h with EX527 (200 μmol/L) or supplemented with exogenous NAD+ (2 mmol/L).

  • 1/16

    NAD+ lithium purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Feb:69:103030. [Abstract]

    Customer Validation
     The declines of cysteine induced by SRT2183 (40 μmol/L) at 24 h were both suppressed by pretreating the cells 1 h with EX527 or supplementing exogenous NAD+ (2 mmol/L).

  • 1/16

    NAD+ lithium purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Feb:69:103030. [Abstract]

    Customer Validation
     Western blotting revealed RSL3-induced downregulation of SLC7A11 and GPX4 was enhanced by FK866, but attenuated by exogenous NAD+ (2 mmol/L) supplement.

  • 1/16

    NAD+ lithium purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Feb:69:103030. [Abstract]

    Customer Validation
     Pretreatment with FK866 (500 μmol/L) or supplement of exogenous NAD+ at 2 mmol/L for 1 h prevented RSL3-induced upregulation of ATF3 in both cytoplasmic and nuclear fractions.

  • 1/16

    NAD+ lithium purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Feb:69:103030. [Abstract]

    Customer Validation
     Supplement of exogenous NAD+ at 1 mmol/L could inhibit ATF3 upregulation in the cells treated with FK866 (500 μmol/L) for 24 h, and this inhibition became more apparent by increasing NAD+ dosage to 2 mmol/L.

  • 1/16

    NAD+ lithium purchased from MedChemExpress. Usage Cited in: Acta Pharmacol Sin. 2023 Oct;44(10):2125-2138. [Abstract]

    Customer Validation
     Western blotting proved supplement of exterior NAD+ (0.5-2 mmol/L, 1 h) dosage-dependently alleviated DPT-induced downregulation of phospho-AKT and upregulation of NOX2, NAT10, phospho-CREB, PARP1, and PAR.

  • 1/16

    NAD+ lithium purchased from MedChemExpress. Usage Cited in: Vascul Pharmacol. 2022 Dec:147:107126. [Abstract]

    Customer Validation
     NAD+ significantly improves the expression of CD31 in the MI mice and DM + MI mice.

  • 1/16

    NAD+ lithium purchased from MedChemExpress. Usage Cited in: Vascul Pharmacol. 2022 Dec:147:107126. [Abstract]

    Customer Validation
     NAD+ significantly improves the expression of VEGF in the MI mice and DM + MI mice.

  • NAD+ lithium